← Back to Search

Telotristat (High-Dose) for Neuroendocrine Tumors

Phase 2
Waitlist Available
Led By Aman Chauhan, MD
Research Sponsored by Aman Chauhan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights

Study Summary

This trial will test whether Telotristat increases the efficacy of Lutetium Lu 177 Dotatate therapy in neuroendocrine tumors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Progression-Free Survival (PFS)
Secondary outcome measures
Median Progression-Free Survival (PFS)
Overall Response Rate (ORR)
Quality of Life (QLQ-C30)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2: High-Dose TelotristatExperimental Treatment1 Intervention
Participants in this group will receive 1500mg Telotristat per day.
Group II: Arm 1: Low-Dose TelotristatExperimental Treatment1 Intervention
Participants in this group will receive 750mg Telotristat per day.

Find a Location

Who is running the clinical trial?

Aman ChauhanLead Sponsor
2 Previous Clinical Trials
35 Total Patients Enrolled
Lowell Anthony, MDLead Sponsor
2 Previous Clinical Trials
27 Total Patients Enrolled
2 Trials studying Neuroendocrine Tumors
27 Patients Enrolled for Neuroendocrine Tumors
TerSera Therapeutics LLCIndustry Sponsor
9 Previous Clinical Trials
1,448 Total Patients Enrolled
2 Trials studying Neuroendocrine Tumors
60 Patients Enrolled for Neuroendocrine Tumors
~0 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top